Skip to main content
ToolsForensic Analysisglaxosmithkline south africa

glaxosmithkline south africa

Supplier Forensic Analysis · Scanned: 2026/05/24

Disclaimer: Statistical patterns flagged for review only. This tool does not determine or imply wrongdoing. All findings require independent verification.
Risk Score
Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK
Compliance
N/A/100
Awards
1
Total Value
R 1,5B

Recent Awards

1 awards · Total: R 1 546 006 874

Showing 5 of 1
HP16-2024EPI: SUPPLY AND DELIVERY OF VACCINES USED IN THE EXPANDED PROGRAMME ON IMMUNISATION (EPI) TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 JANUARY 2024 TO 31 DECEMBER 2026 ERRATUM 1: PLEASE NOTE THAT THE SPECIAL REQUIREMENTS AND CONDITIONS OF CONTRACT (SRCC) AS PUBLISHED WITH THE BID PACK ON 22 JULY 2022 FOR TENDER HP16-2024EPI IS BEING REPLACED WITH THIS ERRATUM.
Health
Ref: HP16-2024EPI
R 1 546 006 874
30 Mar 2023

AI Analysis

Powered by Gemini

AI Forensic Analysis

Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo

or upgrade to Pro Subscription

Risk Assessment

Forensic risk score: 0 out of 100. LOW RISK.Forensic risk score: 0 out of 100. LOW RISK.
0RISK SCORE
LOW RISK

Based on 0 forensic flags detected

Unlock Full Analysis

Get access to all forensic flags, evidence details, and AI-generated audit narratives.

View Full Intelligence Report

Get complete award history, director network, and compliance analysis.

View Report →